Handel INmune Bio, Inc. - INMB CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | - | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.030779% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.013666% | ||||||||
Gebyr natten over, tid | 22:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Tidligere luk* | N/A |
Åben* | N/A |
1-Års Ændring* | N/A |
Dagens Spænd* | N/A |
52-Ugers Spænd | 4.63-11.78 |
Gennemsnitlig Volumen (10 dage) | 61.18K |
Gennemsnitlig Volumen (3 måneder) | 1.10M |
Market Cap | 157.75M |
P/E-forhold | -100.00K |
Udestående aktier | 17.95M |
Omsætning | 440.00K |
EPS | -1.74 |
Dividend (Udbytte %) | N/A |
Beta | 2.04 |
Næste indtjeningsopgørelse | Mar 1, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|
INmune Bio, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total omsætning | 0 | 0 | 0 | 0 | 0.01092 | 0.181 |
Omsætning | 0 | 0 | 0 | 0 | 0.01092 | 0.181 |
Totale Driftsudgifter | 0.27749 | 0.83148 | 12.44 | 7.756 | 12.2386 | 29.334 |
Salgs/Generelle/Admin. Udgifter, Total | 0.126 | 0.54612 | 11.3346 | 6.01606 | 6.3211 | 8.791 |
Forskning & Udvikling | 0.1015 | 0.43536 | 1.10539 | 3.28195 | 5.9175 | 20.543 |
Usædvanlig Udgift (Indkomst) | 0.05 | -0.15 | 0 | |||
Driftsindtægter | -0.27749 | -0.83148 | -12.44 | -7.756 | -12.2277 | -29.153 |
Andre, Netto | 0 | -0.00001 | 0 | 0.12852 | -0.202 | |
Netto Indkomst Før Skat | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Netto Indkomst Efter Skat | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Netto Indkomst Før Ekstra Ting | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Netto Indkomst | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Fortyndet Netto Indkomst | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Fortyndet Vægtet Gennemsnit Aktier | 9.71944 | 9.71944 | 9.74026 | 10.2726 | 11.9885 | 16.1305 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.02855 | -0.08555 | -1.27718 | -0.74745 | -1.00923 | -1.8809 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | |||
Fortyndet Normaliseret EPS | -0.02341 | -0.10098 | -1.27718 | -0.74745 | -1.00923 | -1.8809 |
Other Operating Expenses, Total | -1.542 | |||||
Renteindkomst (Udgift), Netto Ikke-Drift | 0.07769 | -0.985 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total omsætning | 0.004 | 0 | 0.014 | 0.163 | 0.163 |
Omsætning | 0.004 | 0 | 0.014 | 0.163 | 0.163 |
Totale Driftsudgifter | 4.552 | 6.554 | 9.035 | 9.193 | 6.641 |
Salgs/Generelle/Admin. Udgifter, Total | 2.061 | 2.09 | 2.515 | 2.125 | 2.332 |
Forskning & Udvikling | 2.491 | 4.464 | 6.52 | 7.068 | 4.309 |
Driftsindtægter | -4.548 | -6.554 | -9.021 | -9.03 | -6.478 |
Andre, Netto | -0.008 | -0.001 | -0.037 | -0.156 | 0.01 |
Netto Indkomst Før Skat | -4.556 | -6.655 | -9.458 | -9.671 | -6.903 |
Netto Indkomst Efter Skat | -4.556 | -6.655 | -9.458 | -9.671 | -6.903 |
Netto Indkomst Før Ekstra Ting | -4.556 | -6.655 | -9.458 | -9.671 | -6.903 |
Netto Indkomst | -4.556 | -6.655 | -9.458 | -9.671 | -6.903 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -4.556 | -6.655 | -9.458 | -9.671 | -6.903 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | -4.556 | -6.655 | -9.458 | -9.671 | -6.903 |
Fortyndet Netto Indkomst | -4.556 | -6.655 | -9.458 | -9.671 | -6.903 |
Fortyndet Vægtet Gennemsnit Aktier | 14.3227 | 14.9749 | 17.3294 | 17.8621 | 17.8703 |
Fortyndet EPS Uden Ekstraordinære Ting | -0.3181 | -0.44441 | -0.54578 | -0.54142 | -0.38628 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Fortyndet Normaliseret EPS | -0.3181 | -0.44441 | -0.54578 | -0.54142 | -0.38628 |
Renteindkomst (Udgift), Netto Ikke-Drift | -0.1 | -0.4 | -0.485 | -0.435 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Totale Nuværende Aktiver | 0.45161 | 1.89947 | 0.84934 | 7.76478 | 23.9857 | 82.606 |
Likvider og Kortsigtede Investeringer | 0.14166 | 1.37071 | 0.1862 | 6.99553 | 21.9669 | 74.81 |
Likvider & Lignende | 0.14166 | 1.37071 | 0.1862 | 6.99553 | 21.9669 | 74.81 |
Totale Tilgodehavender, Netto | 0.26049 | 0.32761 | 0.64759 | 0.64536 | 1.79875 | 5.504 |
Prepaid Expenses | 0.04946 | 0.20115 | 0.01555 | 0.12389 | 0.22009 | 2.292 |
Total Assets | 0.45161 | 18.4135 | 17.3633 | 24.4703 | 40.6559 | 99.945 |
Intangibles, Net | 0 | 16.514 | 16.514 | 16.514 | 16.514 | 16.514 |
Total Current Liabilities | 0.60081 | 0.30972 | 0.82377 | 0.70038 | 1.77626 | 4.359 |
Payable/Accrued | 0.22081 | 0.30972 | 0.82377 | 0.69209 | 1.55178 | 3.813 |
Notes Payable/Short Term Debt | 0.35 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.03 | 0 | 0.19061 | 0.474 | ||
Total Liabilities | 0.60081 | 0.30972 | 0.82377 | 0.86054 | 1.90255 | 19.72 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 0 | 14.458 |
Total Equity | -0.1492 | 18.1038 | 16.5396 | 23.6098 | 38.7534 | 80.225 |
Common Stock | 0.05507 | 0.05832 | 4.68472 | 0.06077 | 0.01348 | 0.018 |
Additional Paid-In Capital | 0.12493 | 19.1712 | 25.4462 | 44.8337 | 72.1045 | 143.921 |
Retained Earnings (Accumulated Deficit) | -0.32636 | -1.15785 | -13.5979 | -21.2762 | -33.3753 | -63.715 |
Other Equity, Total | -0.00284 | 0.03204 | 0.00653 | -0.00852 | 0.01071 | 0.001 |
Total Liabilities & Shareholders’ Equity | 0.45161 | 18.4135 | 17.3633 | 24.4703 | 40.6559 | 99.945 |
Total Common Shares Outstanding | 9.71944 | 9.71944 | 9.74026 | 10.771 | 13.4813 | 17.8433 |
Property/Plant/Equipment, Total - Net | 0.19154 | 0.15621 | 0.726 | |||
Accrued Expenses | 0.00829 | 0.03387 | 0.072 | |||
Other Liabilities, Total | 0.16016 | 0.12629 | 0.903 | |||
Other Long Term Assets, Total | 0.099 | |||||
Long Term Debt | 14.458 | |||||
Preferred Stock - Non Redeemable, Net | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 49.213 | 44.049 | 90.931 | 82.606 | 77.059 |
Likvider og Kortsigtede Investeringer | 45.34 | 39.52 | 84.471 | 74.81 | 66.729 |
Likvider & Lignende | 45.34 | 39.52 | 84.471 | 74.81 | 66.729 |
Totale Tilgodehavender, Netto | 2.344 | 3.119 | 5.146 | 5.504 | 5.648 |
Prepaid Expenses | 1.529 | 1.41 | 1.314 | 2.292 | 4.682 |
Total Assets | 65.874 | 60.7 | 107.672 | 99.945 | 94.353 |
Property/Plant/Equipment, Total - Net | 0.147 | 0.137 | 0.128 | 0.726 | 0.681 |
Intangibles, Net | 16.514 | 16.514 | 16.514 | 16.514 | 16.514 |
Total Current Liabilities | 2.196 | 2.989 | 4.81 | 4.359 | 3.226 |
Payable/Accrued | 1.582 | 2.37 | 4.231 | 3.813 | 2.56 |
Accrued Expenses | 0.023 | 0.036 | 0.038 | 0.072 | 0.082 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.591 | 0.583 | 0.541 | 0.474 | 0.584 |
Total Liabilities | 2.312 | 17.467 | 19.417 | 19.72 | 18.711 |
Total Long Term Debt | 0 | 14.348 | 14.401 | 14.458 | 14.514 |
Other Liabilities, Total | 0.116 | 0.13 | 0.206 | 0.903 | 0.971 |
Total Equity | 63.562 | 43.233 | 88.255 | 80.225 | 75.642 |
Common Stock | 0.015 | 0.015 | 0.018 | 0.018 | 0.018 |
Additional Paid-In Capital | 101.466 | 87.854 | 142.399 | 143.921 | 146.186 |
Retained Earnings (Accumulated Deficit) | -37.931 | -44.586 | -54.044 | -63.715 | -70.618 |
Other Equity, Total | 0.012 | -0.05 | -0.118 | 0.001 | 0.056 |
Total Liabilities & Shareholders’ Equity | 65.874 | 60.7 | 107.672 | 99.945 | 94.353 |
Total Common Shares Outstanding | 14.9326 | 15.1252 | 13.4813 | 17.8433 | 17.946 |
Long Term Debt | 14.348 | 14.401 | 14.458 | 14.514 | |
Other Long Term Assets, Total | 0.099 | 0.099 | 0.099 | ||
Preferred Stock - Non Redeemable, Net | 0 | 0 |
- Årlig
- Pr kvartal
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Netto indkomst/Startlinje | -0.27749 | -0.83149 | -12.44 | -7.67831 | -12.0992 | -30.34 |
Likvider Fra Driftsaktiviteter | -0.31738 | -0.76183 | -2.05899 | -5.38466 | -8.94365 | -28.504 |
Ikke-Likvide Ting | 0.05 | 0.04956 | 10.0014 | 2.55454 | 3.112 | 4.922 |
Ændringer i Driftskapital | -0.08989 | 0.0201 | 0.37967 | -0.26088 | 0.04351 | -3.086 |
Likvider fra Investeringsaktiviteter | 0 | -0.1 | 0 | -15 | ||
Kapitaludgifter | 0 | -0.1 | 0 | -15 | ||
Likvider fra Financieringsaktiviteter | 0.45 | 2.056 | 0.9 | 12.209 | 23.8958 | 96.357 |
Udstedelse (Pensionering) af Aktier, Netto | 0.1 | 2.056 | 0.9 | 12.209 | 23.8958 | 81.406 |
Udstedelse (Pensionering) af Gæld, Netto | 0.35 | 0 | 14.951 | |||
Udenlandsk Børs Effekter | -0.00284 | 0.03489 | -0.02551 | -0.01504 | 0.01922 | -0.01 |
Netto Ændring i Likviditet | 0.12978 | 1.22905 | -1.18451 | 6.80932 | 14.9714 | 52.843 |
Cash Taxes Paid | 0 | 0 | 0 | |||
Likvid Rente Betalt | 0 | 0 | 0.559 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -4.556 | -11.211 | -20.669 | -30.34 | -6.903 |
Cash From Operating Activities | -5.092 | -10.801 | -18.724 | -28.504 | -8.865 |
Non-Cash Items | 0.899 | 1.684 | 3.343 | 4.922 | 1.592 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Cash Interest Paid | 0 | 0 | 0.265 | 0.559 | 0.291 |
Changes in Working Capital | -1.435 | -1.274 | -1.398 | -3.086 | -3.554 |
Cash From Financing Activities | 28.464 | 43.415 | 96.357 | 96.357 | 0.729 |
Issuance (Retirement) of Stock, Net | 28.464 | 28.464 | 81.406 | 81.406 | 0.729 |
Foreign Exchange Effects | 0.001 | -0.061 | -0.129 | -0.01 | 0.055 |
Net Change in Cash | 23.373 | 17.553 | 62.504 | 52.843 | -8.081 |
Cash From Investing Activities | -15 | -15 | -15 | ||
Capital Expenditures | -15 | -15 | |||
Issuance (Retirement) of Debt, Net | 14.951 | 14.951 | 14.951 | ||
Other Investing Cash Flow Items, Total | -15 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
Xencor Inc | Corporation | 10.5067 | 1885533 | 0 | 2022-04-10 | |
Tesi (Raymond Joseph) | Individual Investor | 8.4737 | 1520698 | 6300 | 2022-05-26 | LOW |
Lowdell (Mark William) | Individual Investor | 8.3383 | 1496383 | 0 | 2022-04-10 | LOW |
Moss (David J.) | Individual Investor | 6.9523 | 1247651 | 10700 | 2022-05-27 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.0168 | 541398 | -12240 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.2881 | 231155 | -1274 | 2022-09-30 | LOW |
Janney Montgomery Scott LLC | Research Firm | 1.2514 | 224579 | 29093 | 2022-12-31 | LOW |
ACT Capital Management, L.L.C. | Hedge Fund | 0.842 | 151100 | -9400 | 2022-09-30 | MED |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7779 | 139606 | 1382 | 2022-09-30 | LOW |
Morgan Stanley & Co. LLC | Research Firm | 0.7074 | 126950 | -79282 | 2022-09-30 | MED |
Deutsche Asset Management Americas | Investment Advisor/Hedge Fund | 0.6745 | 121048 | 0 | 2022-09-30 | LOW |
Schroeder (Timothy J) | Individual Investor | 0.5137 | 92187 | -64480 | 2022-04-10 | |
RBC Dominion Securities, Inc. | Investment Advisor | 0.3344 | 60009 | 1642 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2505 | 44963 | 0 | 2022-09-30 | LOW |
UBS Financial Services, Inc. | Investment Advisor | 0.2226 | 39950 | 1000 | 2022-09-30 | LOW |
Group One Trading, L.P. | Research Firm | 0.2015 | 36156 | 2683 | 2022-09-30 | HIGH |
Westside Investment Management, Inc | Investment Advisor | 0.1693 | 30390 | 150 | 2022-12-31 | LOW |
Juda (Scott) | Individual Investor | 0.1672 | 30000 | 2500 | 2022-04-10 | |
Millennium Management LLC | Hedge Fund | 0.1514 | 27169 | 27169 | 2022-09-30 | HIGH |
Citadel Advisors LLC | Hedge Fund | 0.1456 | 26132 | 9469 | 2022-09-30 | HIGH |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com GroupHandlende
Månedlkige, aktive klienter
Månedlig investeringsvolumen
Hævet hver måned
Handelslommeregner
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
INmune Bio, Inc. Company profile
Om INmune Bio, Inc.
INmune Bio, Inc. er en bioteknologisk virksomhed på klinisk stadie. Selskabet er fokuseret på at udvikle og markedsføre sine produktkandidater til behandling af sygdomme, hvor det medfødte immunsystem ikke fungerer normalt og bidrager til patientens sygdom. Selskabet har to produktplatforme. DN-TNF-produktplatformen anvender dominant-negativ teknologi til selektivt at neutralisere opløseligt TNF, som er en drivkraft for den medfødte immunforsvarsdysfunktion og et mekanistisk mål for mange sygdomme. DN-TNF er under udvikling til behandling af COVID-19-komplikationer (Quellor), kræft (INB03), Alzheimers sygdom og behandlingsresistent depression (XPro595) og NASH (LIVNate). Platform for priming af naturlige dræberceller (NK) omfatter INKmune til priming af patientens NK-celler med henblik på at fjerne minimal restsygdom hos patienter med kræft. Selskabets produktplatforme anvender en præcisionsmedicinsk tilgang til behandling af en række forskellige hæmatologiske maligniteter, solide tumorer og kroniske inflammationer.
Industry: | Bio Therapeutic Drugs |
225 Ne Mizner Blvd, Suite 640
BOCA RATON
FLORIDA 33432
US
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com